(2020) COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper. Basic and Clinical Neuroscience. pp. 133-149. ISSN 2008-126X
Full text not available from this repository.
Abstract
Coronavirus Disensr 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to glass, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper', an international group of experts on addiction medicine, infectious diseases, and disater psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).
| Item Type: | Article |
|---|---|
| Keywords: | Coronavirus Coronavirus Discase 2019 (COVID-19) Pandemic Public health Substance use disorder Addiction medicine Harm reduction Policy Methadone Opioid substitution therapy CONTINGENCY MANAGEMENT INTERVENTIONS RESPIRATORY SYNDROME CORONAVIRUS METHADONE-MAINTENANCE PATIENTS TORSADE-DE-POINTES DRUG-USERS CROSS-TOLERANT COCAINE ABUSE SAUDI-ARABIA RISK-FACTORS STRESS |
| Subjects: | WC Communicable Diseases > WC 500-590 Virus Diseases |
| Divisions: | Cancer Prevention Research Center |
| Page Range: | pp. 133-149 |
| Journal or Publication Title: | Basic and Clinical Neuroscience |
| Journal Index: | ISI |
| Volume: | 11 |
| Number: | 2 |
| Identification Number: | https://doi.org/10.32598/bcn.11.covid19.1 |
| ISSN: | 2008-126X |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/12511 |
Actions (login required)
 |
View Item |